GTR Home > Tests > Search results - HSPB8[gene]

Apply filters

Showing tests for all 1691 conditions

Compare labs

Your search term can be found in tests with a total of 1691 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for 26353[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 36 tests for 1691 conditions in 15 labs

CCMT2L

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeuronopathy distal hereditary motor type IIA

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CHSPB8. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CDistal Hereditary Motor Neuropathy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (22)
Total targets (17)

CHeat Shock 22 kDa Protein-Related Disorders via the HSPB8 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CCharcot-Marie-Tooth disease type 2L (CMT2L, sequence analysis of HSPB8 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CHereditary peripheral neuropathies, including Charcot-Marie-Tooth disease (NGS panel for 74 genes)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total targets (74)

CSpinal Muscular Atrophy (SMA) Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (44)
Total targets (22)

CCharcot-Marie-Tooth and Sensory Neuropathies Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (65)
Total targets (83)

CSpinal Muscular Atrophy Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany

CHereditary Spastic Paraplegias (HSP) and differential diagnoses Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (147)
Total targets (133)

CNeuropathy

Total conditions (7)
Total targets (122)

CNeuronopathy distal hereditary motor type IIA (sequence analysis of HSPB8 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCharcot-Marie-Tooth Disease

Lab: Asper Biotech Asper Biotech Ltd. Tartu, Tartumaa, Estonia
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (45)
Total targets (30)

CHSPB8

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 36 tests for 1691 conditions in 15 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.